UNSPSC 85814717: Introduction of other antineoplastic into female reproductive, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into female reproductive, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0P305

UNSPSC 85814717, Introduction of other antineoplastic into female reproductive, percutaneous approach, is a Commodity code with little relevant recent state and local procurement activity. The code nominally describes a medical procedure for cancer treatment, yet the recent opportunities bearing this code designation reflect a broad mix of primary care, occupational health, behavioral health, and emergency services — none of which align with the code's stated antineoplastic scope. State and local buyers are not using this code to procure the specialized oncological intervention its name suggests.

The mismatch signals either a data-entry error in how opportunities were tagged to the code, or a systematic disconnect between the UNSPSC taxonomy and how some state and local procurement offices classify healthcare services. When a Commodity code shows no concrete recent solicitations for the work its name describes — and instead shows unrelated healthcare demand — the code itself is not a reliable signal for business development targeting. Monitor this code's activity for future pattern changes, but do not expect near-term volume in antineoplastic drug administration based on the current posting record.